Page last updated: 2024-12-05

1-amino-2,4-dibromoanthraquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-amino-2,4-dibromoanthraquinone is an organic compound with the chemical formula C14H7Br2NO2. It is a derivative of anthraquinone, a large polycyclic aromatic hydrocarbon, with the addition of an amino group and two bromine atoms.

Here's why it's important for research:

* **Dye Synthesis:** 1-amino-2,4-dibromoanthraquinone serves as a valuable intermediate in the synthesis of various dyes. Its reactive amino and bromine groups allow for further chemical modifications and the formation of diverse colorants. This includes dyes for textiles, plastics, and other materials.
* **Organic Electronics:** Anthraquinone derivatives, including this one, are explored for applications in organic electronics due to their unique electronic properties. Their conjugated systems can contribute to charge transport, making them potentially useful in organic solar cells, organic light-emitting diodes (OLEDs), and other devices.
* **Materials Science:** 1-amino-2,4-dibromoanthraquinone's structure and functional groups make it a promising building block for creating novel materials with specific properties. Its rigid aromatic core and reactive functional groups can be tailored for applications in polymers, liquid crystals, and even nano-scale materials.
* **Medicinal Chemistry:** Some anthraquinone derivatives have shown biological activity, making them potential leads for drug development. While 1-amino-2,4-dibromoanthraquinone itself might not possess therapeutic value, it could be a starting point for synthesizing new compounds with desired biological properties.

**Note:** The exact research interest in 1-amino-2,4-dibromoanthraquinone may vary based on the specific research group and the field of study. Its importance often arises from its potential as a versatile building block for synthesizing other compounds with diverse applications.

1-amino-2,4-dibromoanthraquinone: intermediate in the production of dyes [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6681
CHEMBL ID559749
CHEBI ID82304
SCHEMBL ID3272427
MeSH IDM0137806

Synonyms (55)

Synonym
AC-13906
nsc3529
1-amino-2,4-dibromanthrachinon
dibromoaminoanthraquinone
2,4-dibromo-1-anthraquinonylamine
wln: l c666 bv ivj dz ee ge
81-49-2
1-amino-2,4-dibromoanthraquinone
nci-c55458
anthraquinone,4-dibromo-
nsc-3529
9, 1-amino-2,4-dibromo-
9,10-anthracenedione, 1-amino-2,4-dibromo-
anthraquinone, 1-amino-2,4-dibromo-
1-amino-2,4-dibromo-anthraquinone
1-amino-2,4-dibromo-9,10-anthraquinone
brn 1993373
einecs 201-354-0
hsdb 5241
ccris 5884
1-amino-2,4-dibromanthrachinon [czech]
nsc 3529
ai3-16445
AE-641/00127034
1-amino-2,4-dibromoanthra-9,10-quinone
chebi:82304 ,
CHEMBL559749
1-amino-2,4-dibromoanthra-quinone
AKOS000668885
STK803590
1-amino-2,4-dibromoanthracene-9,10-dione
A840149
unii-rf75o3ikoz
rf75o3ikoz ,
4-14-00-00444 (beilstein handbook reference)
C19211
dtxsid4039235 ,
tox21_202582
dtxcid9052
NCGC00260131-01
cas-81-49-2
BBL013158
FT-0607312
1-amino-2,4-dibromoanthraquinone [iarc]
SCHEMBL3272427
naproxenmethylester
W-104207
1-amino-2, 4-dibromoanthraquinone
mfcd00019155
AS-61164
1-amino-2,4-dibromo-9,10-dihydroanthracene-9,10-dione
l-amino-2,4-dibromoanthraquinone
Q27155867
E76133
CS-0188511

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The toxicity of chemicals can be enhanced by light through two photochemical pathways: Photomodification to more toxic substances and photosensitization."( Combined experimental and theoretical study on photoinduced toxicity of an anthraquinone dye intermediate to Daphnia magna.
Bian, H; Cai, X; Chen, J; Hao, C; Lin, J; Wang, Y; Wang, Z, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
anthraquinone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency6.52290.000221.22318,912.5098AID743035
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency6.59190.001022.650876.6163AID1224838; AID1224893
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency15.35740.001530.607315,848.9004AID1224848; AID1224849
farnesoid X nuclear receptorHomo sapiens (human)Potency3.26920.375827.485161.6524AID743220
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency6.52290.001019.414170.9645AID743191
aryl hydrocarbon receptorHomo sapiens (human)Potency5.31070.000723.06741,258.9301AID743085; AID743122
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency12.53940.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID433903Hepatotoxicity in mouse assessed as carcinogenic potency2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.32 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]